Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan;29(1):188-190.
doi: 10.3350/cmh.2022.0408. Epub 2022 Nov 22.

Correspondence on Editorial regarding "Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients"

Yu Jun Wong  1   2 , Sanchit Sharma  3 , Giulia Tosetti  4 , Xiaolong Qi  5 , Massimo Primignani  4
Affiliations
Comment

Correspondence on Editorial regarding "Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients"

Yu Jun Wong et al. Clin Mol Hepatol. 2023 Jan.
No abstract available

Keywords: Ascites; Hepatic encephalopathy; Hypertension; Liver cirrhosis; Portal.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

YJW is an invited speaker for Gilead Science and AbbVie. The other authors have no conflicts to disclose.

Comment on

References

    1. Semmler G, Jachs M, Mandorfer M. Non-invasive tests-based risk stratification: Baveno VII and beyond. Clin Mol Hepatol. 2023;29:105–109. - PMC - PubMed
    1. Wong YJ, Zhaojin C, Tosetti G, Degasperi E, Sharma S, Agarwal S, et al. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin Mol Hepatol. 2023;29:135–145. - PMC - PubMed
    1. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Clin Liver Dis (Hoboken) 2018;12:33–34. - PMC - PubMed
    1. Lens S, Baiges A, Alvarado-Tapias E, LLop E, Martinez J, Fortea JI, et al. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. J Hepatol. 2020;73:1415–1424. - PubMed
    1. European Association for the Study of the Liver EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73:1170–1218. - PubMed

MeSH terms

Substances